Phase 2 COPD trials recruiting now

All COPD trials, every phase

Other phases for COPD

Phase 2 COPD trials

• "The Effect of Inhaled Nitroglycerin for COPD Patients
  NCT06785337 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
  NCT07640451 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
  NCT07418736 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · 1 location
• A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD
  NCT07351734 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
  NCT07725939 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 7 locations
• A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
  NCT07646587 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 21 locations
• A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD
  NCT07668518 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 2 locations
• A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
  NCT07292714 · Phase: Phase 2 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 51 locations
• A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease
  NCT07349524 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
  NCT07082738 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · 367 locations
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
  NCT07363694 · Phase: Phase 2, Phase 3 · Ages: 35 Years to 80 Years · Sex: All (male and female) · 120 locations
• Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
  NCT04147286 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
  NCT05937854 · Phase: Phase 2 · Ages: 35 Years to 89 Years · Sex: All (male and female) · 5 locations
• Cell Therapy Associated With Endobronchial Valve
  NCT04018729 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
  NCT07059091 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · 23 locations
• Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
  NCT05270525 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 3 locations
• Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
  NCT05507242 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · 2 locations
• Efficacy of Morphine in Reducing the Rate of Early Non-Invasive Ventilation Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Phase I/IIa
  NCT04427826 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)
  NCT07140328 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• Feasibility of Semaglutide in Advanced Lung Disease
  NCT05746039 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy
  NCT03331302 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
  NCT06110403 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
  NCT07037836 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
  NCT03500731 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 2 locations
• Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD
  NCT05061368 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• Phase II Study of RC1416 Injection in COPD
  NCT07402551 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · 46 locations
• Psilocybin Therapy for Psychological Distress in Palliative Patients
  NCT06782724 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Pulmonary Hypertension SOLAR
  NCT04778046 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translational Application Study
  NCT06946953 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 2 locations
• Rademikibart IV for Acute Asthma and COPD Exacerbation
  NCT07705737 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 4 locations
• The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
  NCT05237505 · Phase: Phase 2 · Ages: 40 Years to 79 Years · Sex: All (male and female) · 1 location
• To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
  NCT07684820 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · 20 locations
• Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells
  NCT06491043 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 2 locations
• Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
  NCT07610395 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · 41 locations
• Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients
  NCT07441226 · Phase: Phase 2 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• cfMSC Stem Cell Therapy Targeting COPD
  NCT07477600 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.